As of May 26
| -1.07 / -6.24%|
The 6 analysts offering 12-month price forecasts for Insmed Inc have a median target of 25.00, with a high estimate of 35.00 and a low estimate of 14.00. The median estimate represents a +55.57% increase from the last price of 16.07.
The current consensus among 7 polled investment analysts is to Buy stock in Insmed Inc. This rating has held steady since May, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.